Robin H. Bogner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Robin H. Bogner has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
Michael J. Pikal
University of Connecticut, Storrs, USA
7 shared publicationsArushi Manchanda
Department of Pharmaceutical Sciences, University of Connecticut, Storrs, USA
4 shared publicationsRui Fang
University of Connecticut, Storrs, USA
4 shared publicationsMary S. Kleppe
Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut 06269
3 shared publicationsBakul S. Bhatnagar
School of Pharmacy, U-3092, University of Connecticut, Storrs, Connecticut 06269, USA
2 shared publications- Bodhisattwa Chaudhuri
Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, USA
2 shared publications
Latest Publications
- Open Access
- 5 June 2026
- Published by Springer Nature in AAPS Open
- Vol. 12 (1)
Dielectric properties of sucrose solutions: role of free water and hydration dynamics in microwave-assisted freeze-drying (MAFD) at 2.45 GHz
- 5 June 2026
- Published by Springer Nature in AAPS Open
- Vol. 12 (1)
Open AccessDielectric properties of sucrose solutions: role of free water and hydration dynamics in microwave-assisted freeze-drying (MAFD) at 2.45 GHz
- 26 February 2025
- Published by Springer Nature in Pharmaceutical Research
- Vol. 42 (3) , 413-418
Advanced Manufacturing, Modeling And Analytical Tools In Injectable Products
Although great progress has been made in the effectiveness and availability of medicines, there is still more work to do assuring greater access and continuing to advance disease treatments. Recent advances in both the types of treatments that can be developed and the technology to produce, characterize, collect relevant data from, and deliver medicines to patients have accelerated in recent experience. The National Institute for Pharmaceutical Technology and Education assembled representatives from academia, industry, and health authorities to assess progress. This article gives a perspective on recent trends in advanced manufacturing of injectable pharmaceutical products and provides some insight from which pharmaceutical manufacturers may implement valuable improvements based on these technological advances.
- 26 February 2025
- Published by Springer Nature in Pharmaceutical Research
- Vol. 42 (3) , 413-418
Advanced Manufacturing, Modeling And Analytical Tools In Injectable Products
Although great progress has been made in the effectiveness and availability of medicines, there is still more work to do assuring greater access and continuing to advance disease treatments. Recent advances in both the types of treatments that can be developed and the technology to produce, characterize, collect relevant data from, and deliver medicines to patients have accelerated in recent experience. The National Institute for Pharmaceutical Technology and Education assembled representatives from academia, industry, and health authorities to assess progress. This article gives a perspective on recent trends in advanced manufacturing of injectable pharmaceutical products and provides some insight from which pharmaceutical manufacturers may implement valuable improvements based on these technological advances.
- 5 September 2023
- Published by Springer Nature in Pharmaceutical Research
- Vol. 40 (12) , 2769-2778
Effect of Structurally Related Compounds on Desupersaturation Kinetics of Indomethacin
Purpose The pharmaceutical literature contains examples wherein desupersaturation from high concentrations does not proceed to equilibrium concentration of the thermodynamically most stable form but remains above equilibrium. The purpose of the current research was to investigate the effect of structurally related compounds on desupersaturation kinetics as a possible explanation for a higher than equilibrium solubility after crystal growth of γ-indomethacin (γ-IMC). Methods Three structurally related compounds (SRC) – cis-sulindac (c-SUL), trans-sulindac (t-SUL) and indomethacin-related compound-A (IMC-A) –were investigated. Desupersaturation kinetics to the most stable γ-IMC, in the presence of c-SUL, t-SUL or IMC-A, was measured at pH 2.0. Results The SRCs c-SUL and t-SUL were effective crystallization inhibitors of IMC, while IMC-A was not a potent crystallization inhibitor of IMC. Among the sulindac isomers, t-SUL was a stronger crystallization inhibitor. The apparent solubility of γ-IMC crystals grown from supersaturated solutions in the presence of SRCs matched the equilibrium solubility of γ-IMC. During crystallization of IMC in the presence of IMC-A, the concentration of IMC-A declined initially but rebounded as supersaturation and crystallization rate of IMC declined, suggesting that IMC-A itself became incorporated in the IMC crystal lattice at higher degrees of IMC supersaturation. Conclusions The results suggest that high apparent solubility after crystallization of IMC reported by several authors is not related to the presence of IMC-A impurity. The greater IMC crystal growth rate inhibition by t-SUL than by c-SUL was consistent with the proposed orientation of SUL molecules adsorbed on the IMC crystal, providing a mechanistic understanding of the inhibition.
- 5 September 2023
- Published by Springer Nature in Pharmaceutical Research
- Vol. 40 (12) , 2769-2778
Effect of Structurally Related Compounds on Desupersaturation Kinetics of Indomethacin
Purpose The pharmaceutical literature contains examples wherein desupersaturation from high concentrations does not proceed to equilibrium concentration of the thermodynamically most stable form but remains above equilibrium. The purpose of the current research was to investigate the effect of structurally related compounds on desupersaturation kinetics as a possible explanation for a higher than equilibrium solubility after crystal growth of γ-indomethacin (γ-IMC). Methods Three structurally related compounds (SRC) – cis-sulindac (c-SUL), trans-sulindac (t-SUL) and indomethacin-related compound-A (IMC-A) –were investigated. Desupersaturation kinetics to the most stable γ-IMC, in the presence of c-SUL, t-SUL or IMC-A, was measured at pH 2.0. Results The SRCs c-SUL and t-SUL were effective crystallization inhibitors of IMC, while IMC-A was not a potent crystallization inhibitor of IMC. Among the sulindac isomers, t-SUL was a stronger crystallization inhibitor. The apparent solubility of γ-IMC crystals grown from supersaturated solutions in the presence of SRCs matched the equilibrium solubility of γ-IMC. During crystallization of IMC in the presence of IMC-A, the concentration of IMC-A declined initially but rebounded as supersaturation and crystallization rate of IMC declined, suggesting that IMC-A itself became incorporated in the IMC crystal lattice at higher degrees of IMC supersaturation. Conclusions The results suggest that high apparent solubility after crystallization of IMC reported by several authors is not related to the presence of IMC-A impurity. The greater IMC crystal growth rate inhibition by t-SUL than by c-SUL was consistent with the proposed orientation of SUL molecules adsorbed on the IMC crystal, providing a mechanistic understanding of the inhibition.
- 24 September 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 112 (2) , 482-491
Large-Scale Freeze-Thaw of Protein Solutions: Study of the Relative Contributions of Freeze-Concentration and Ice Surface Area on Stability of Lactate Dehydrogenase
- 24 September 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 112 (2) , 482-491
Large-Scale Freeze-Thaw of Protein Solutions: Study of the Relative Contributions of Freeze-Concentration and Ice Surface Area on Stability of Lactate Dehydrogenase
- 22 September 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 112 (2) , 573-586
Evaluation of a Raman Chemometric Method for Detecting Protein Structural Conformational Changes in Solution
- 22 September 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 112 (2) , 573-586
Evaluation of a Raman Chemometric Method for Detecting Protein Structural Conformational Changes in Solution
- 1 August 2021
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 165, 361-373
Key factors governing the reconstitution time of high concentration lyophilized protein formulations
- 1 August 2021
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 165, 361-373
Key factors governing the reconstitution time of high concentration lyophilized protein formulations
- 17 February 2021
- Published by Springer Nature in Pharmaceutical Research
- Vol. 38 (2) , 379
Correction to: Evaluation of Predictors of Protein Relative Stability Obtained by \Solid-State Hydrogen/Deuterium Exchange Monitored by FTIR
- 17 February 2021
- Published by Springer Nature in Pharmaceutical Research
- Vol. 38 (2) , 379
Correction to: Evaluation of Predictors of Protein Relative Stability Obtained by \Solid-State Hydrogen/Deuterium Exchange Monitored by FTIR
- 1 October 2020
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 109 (10) , 2975-2985
Reconstitution Time for Highly Concentrated Lyophilized Proteins: Role of Formulation and Protein
- 1 October 2020
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 109 (10) , 2975-2985
Reconstitution Time for Highly Concentrated Lyophilized Proteins: Role of Formulation and Protein
- 13 August 2020
- Published by Springer Nature in Pharmaceutical Research
- Vol. 37 (9) , 1-9
Evaluation of Predictors of Protein Relative Stability Obtained by Solid-State Hydrogen/Deuterium Exchange Monitored by FTIR
Purpose Hydrogen/deuterium (H/D) exchange over a range of temperatures suggests a protein structural/mobility transition in the solid state below the system glass transition temperature (Tg). The purpose of this study was to determine whether solid-state protein stability correlates with the difference between storage temperature and apparent Td where an abrupt change in mobility occurs, or alternatively, the extent of H/D exchange at a single temperature correlates directly to protein stability in lyophilized solids. Methods Solid-state H/D exchange was monitored by FTIR spectroscopy to study the extent of exchange and the apparent transition temperature in both pure recombinant human serum albumin (rHSA) and rHSA formulated with sucrose or trehalose. H/D exchange of freeze-dried formulations at 11% RH and temperatures from 30 to 80°C was monitored. Protein stability against aggregation at 40°C/11% RH for 6 months was assessed by size exclusion chromatography (SEC). Results Both sucrose and trehalose showed equivalent protection of protein secondary structure by FTIR. The rHSA:sucrose formulation showed superior long-term stability at 40°C by SEC over the trehalose formulation, but the apparent Td determined from H/D exchange was much higher in the trehalose formulation. Instead, the extent of H/D exchange (X∞) was lower in the sucrose formulation at the temperature of the stability studies (40°C) than found for the trehalose formulation, which was consistent with better stability in the sucrose formulation. Conclusions While apparent Td did not correlate with protein stability for rHSA, the extent of H/D exchange, X∞, did.
- 13 August 2020
- Published by Springer Nature in Pharmaceutical Research
- Vol. 37 (9) , 1-9
Evaluation of Predictors of Protein Relative Stability Obtained by Solid-State Hydrogen/Deuterium Exchange Monitored by FTIR
Purpose Hydrogen/deuterium (H/D) exchange over a range of temperatures suggests a protein structural/mobility transition in the solid state below the system glass transition temperature (Tg). The purpose of this study was to determine whether solid-state protein stability correlates with the difference between storage temperature and apparent Td where an abrupt change in mobility occurs, or alternatively, the extent of H/D exchange at a single temperature correlates directly to protein stability in lyophilized solids. Methods Solid-state H/D exchange was monitored by FTIR spectroscopy to study the extent of exchange and the apparent transition temperature in both pure recombinant human serum albumin (rHSA) and rHSA formulated with sucrose or trehalose. H/D exchange of freeze-dried formulations at 11% RH and temperatures from 30 to 80°C was monitored. Protein stability against aggregation at 40°C/11% RH for 6 months was assessed by size exclusion chromatography (SEC). Results Both sucrose and trehalose showed equivalent protection of protein secondary structure by FTIR. The rHSA:sucrose formulation showed superior long-term stability at 40°C by SEC over the trehalose formulation, but the apparent Td determined from H/D exchange was much higher in the trehalose formulation. Instead, the extent of H/D exchange (X∞) was lower in the sucrose formulation at the temperature of the stability studies (40°C) than found for the trehalose formulation, which was consistent with better stability in the sucrose formulation. Conclusions While apparent Td did not correlate with protein stability for rHSA, the extent of H/D exchange, X∞, did.